Ken Griffin Citadel Advisors
AUM $115B
1-Year Return
4.22%
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
This Quarter Return
+2.1%
1 Year Return
+4.22%
3 Year Return
+14.25%
5 Year Return
+23%
10 Year Return
+57.51%
AUM
$115B
AUM Growth
+$13.1B
(+13%)
Cap. Flow
+$3.28B
Cap. Flow
% of AUM
2.85%
Top 10 Holdings %
Top 10 Hldgs %
8.55%
Holding
7,447
New
1,273
Increased
2,296
Reduced
2,131
Closed
1,385
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Microsoft
MSFT
|
+$928M |
| 3 |
McDonald's
MCD
|
+$762M |
| 4 |
Amazon
AMZN
|
+$716M |
| 5 |
Coca-Cola
KO
|
+$650M |
Top Sells
| 1 |
Charles Schwab
SCHW
|
+$1.78B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.22B |
| 3 |
Strategy Inc Common Stock Class A
MSTR
|
+$625M |
| 4 |
Kroger
KR
|
+$547M |
| 5 |
Danaher
DHR
|
+$504M |
Sector Composition
| 1 | Technology | 16.69% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 12.79% |
| 4 | Financials | 12.71% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELEV
5126
DELISTED
Elevation Oncology
ELEV
| $130K | ﹤0.01% |
+355,203
| New | +$130K |
|
5127
Dakota Gold
DC
$503M
| $130K | ﹤0.01% |
35,307
+35,179
| +27,484% | +$130K |
|
5128
Data I/O
DAIO
$31.7M
| $130K | ﹤0.01% |
42,369
+1,148
| +3% | +$3.52K |
|
5129
Forafric Global
AFRI
$233M
| $130K | ﹤0.01% |
16,609
+5,008
| +43% | +$39.1K |
|
5130
Nautilus Biotechnolgy
NAUT
$94.8M
| $129K | ﹤0.01% |
178,155
+75,227
| +73% | +$54.5K |
|
5131
AXT Inc
AXTI
$185M
| $129K | ﹤0.01% |
+61,760
| New | +$129K |
|
5132
UNIFI
UFI
$84.6M
| $128K | ﹤0.01% |
24,596
+50
| +0.2% | +$261 |
|
|
TKLF
5133
Yoshitsu Co
TKLF
$15.7M
| $127K | ﹤0.01% |
33,680
-10,282
| -23% | -$38.9K |
|
5134
Angel Oak Mortgage-Backed Securities ETF
MBS
$155M
| $127K | ﹤0.01% |
+14,735
| New | +$127K |
|
5135
Ark Restaurants
ARKR
$25.5M
| $127K | ﹤0.01% |
13,917
+3,233
| +30% | +$29.5K |
|
5136
Pluri
PLUR
$38.5M
| $126K | ﹤0.01% |
+25,438
| New | +$126K |
|
5137
Nuveen New York Tax-Free Income Portfolio
NXN
$47.4M
| $126K | ﹤0.01% |
+10,805
| New | +$126K |
|
|
BRR
5138
Columbus Circle Capital Corp I Class A Ordinary Shares
BRR
$347M
| $125K | ﹤0.01% |
+11,802
| New | +$125K |
|
5139
Greenwich LifeSciences
GLSI
$154M
| $125K | ﹤0.01% |
13,768
+454
| +3% | +$4.12K |
|
|
LPBBU
5140
Launch Two Acquisition Corp. Unit
LPBBU
| $124K | ﹤0.01% |
11,647
+121
| +1% | +$1.29K |
|
|
MOGO
5141
Mogo
MOGO
$43.7M
| $124K | ﹤0.01% |
98,538
+33,887
| +52% | +$42.7K |
|
5142
Nexa Resources
NEXA
$697M
| $123K | ﹤0.01% |
24,876
+12,318
| +98% | +$61.1K |
|
|
MDCX
5143
Medicus Pharma Ltd. Common Stock
MDCX
$53.7M
| $123K | ﹤0.01% |
+41,099
| New | +$123K |
|
|
FGMC
5144
FG Merger II Corp. Common stock
FGMC
$103M
| $122K | ﹤0.01% |
+12,411
| New | +$122K |
|
5145
United-Guardian
UG
$37.6M
| $122K | ﹤0.01% |
15,310
+4,383
| +40% | +$34.9K |
|
|
LGVN
5146
Longeveron
LGVN
$15.6M
| $122K | ﹤0.01% |
+93,653
| New | +$122K |
|
5147
BlackRock MuniVest Fund
MVF
$398M
| $121K | ﹤0.01% |
18,431
-10,534
| -36% | -$69.3K |
|
5148
SOPHiA GENETICS
SOPH
$218M
| $121K | ﹤0.01% |
39,111
+26,976
| +222% | +$83.6K |
|
5149
INNOVATE Corp
VATE
$62.4M
| $121K | ﹤0.01% |
+23,531
| New | +$121K |
|
|
PLG
5150
Platinum Group Metals
PLG
$201M
| $121K | ﹤0.01% |
+79,044
| New | +$121K |
|